Literature DB >> 33670842

A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19.

Anubhav Kanwar1, Alex Jordan2, Scott Olewiler1, Kurt Wehberg3, Michael Cortes4, Brendan R Jackson5.   

Abstract

We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.

Entities:  

Keywords:  COVID-19; Rhizopus; mucormycosis; pneumonia

Year:  2021        PMID： 33670842      PMCID： PMC7997212          DOI： 10.3390/jof7030174

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN： 2309-608X


  17 in total

1.  Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients.

Authors:  Leonardo Potenza; Daniela Vallerini; Patrizia Barozzi; Giovanni Riva; Fabio Forghieri; Eleonora Zanetti; Chiara Quadrelli; Anna Candoni; Johan Maertens; Giulio Rossi; Monica Morselli; Mauro Codeluppi; Ambra Paolini; Monica Maccaferri; Cinzia Del Giovane; Roberto D'Amico; Fabio Rumpianesi; Monica Pecorari; Francesca Cavalleri; Roberto Marasca; Franco Narni; Mario Luppi
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

Review 2.  A higher-level phylogenetic classification of the Fungi.

Authors:  David S Hibbett; Manfred Binder; Joseph F Bischoff; Meredith Blackwell; Paul F Cannon; Ove E Eriksson; Sabine Huhndorf; Timothy James; Paul M Kirk; Robert Lücking; H Thorsten Lumbsch; François Lutzoni; P Brandon Matheny; David J McLaughlin; Martha J Powell; Scott Redhead; Conrad L Schoch; Joseph W Spatafora; Joost A Stalpers; Rytas Vilgalys; M Catherine Aime; André Aptroot; Robert Bauer; Dominik Begerow; Gerald L Benny; Lisa A Castlebury; Pedro W Crous; Yu-Cheng Dai; Walter Gams; David M Geiser; Gareth W Griffith; Cécile Gueidan; David L Hawksworth; Geir Hestmark; Kentaro Hosaka; Richard A Humber; Kevin D Hyde; Joseph E Ironside; Urmas Kõljalg; Cletus P Kurtzman; Karl-Henrik Larsson; Robert Lichtwardt; Joyce Longcore; Jolanta Miadlikowska; Andrew Miller; Jean-Marc Moncalvo; Sharon Mozley-Standridge; Franz Oberwinkler; Erast Parmasto; Valérie Reeb; Jack D Rogers; Claude Roux; Leif Ryvarden; José Paulo Sampaio; Arthur Schüssler; Junta Sugiyama; R Greg Thorn; Leif Tibell; Wendy A Untereiner; Christopher Walker; Zheng Wang; Alex Weir; Michael Weiss; Merlin M White; Katarina Winka; Yi-Jian Yao; Ning Zhang
Journal:  Mycol Res       Date:  2007-03-13

Review 3.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

4.  Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).

Authors:  Thomas J Walsh; Maria N Gamaletsou; Michael R McGinnis; Randall T Hayden; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

5.  Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

Authors:  Paul E Verweij; Bart J A Rijnders; Roger J M Brüggemann; Elie Azoulay; Matteo Bassetti; Stijn Blot; Thierry Calandra; Cornelius J Clancy; Oliver A Cornely; Tom Chiller; Pieter Depuydt; Daniele Roberto Giacobbe; Nico A F Janssen; Bart-Jan Kullberg; Katrien Lagrou; Cornelia Lass-Flörl; Russell E Lewis; Peter Wei-Lun Liu; Olivier Lortholary; Johan Maertens; Ignacio Martin-Loeches; M Hong Nguyen; Thomas F Patterson; Thomas R Rogers; Jeroen A Schouten; Isabel Spriet; Lore Vanderbeke; Joost Wauters; Frank L van de Veerdonk
Journal:  Intensive Care Med       Date:  2020-06-22       Impact factor: 17.440

6.  A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.

Authors:  Daniela Pasero; Silvana Sanna; Corrado Liperi; Davide Piredda; Gian Pietro Branca; Lorenzo Casadio; Raffaella Simeo; Alice Buselli; Davide Rizzo; Francesco Bussu; Salvatore Rubino; Pierpaolo Terragni
Journal:  Infection       Date:  2020-12-17       Impact factor: 3.553

Review 7.  Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

Authors:  Philipp Koehler; Matteo Bassetti; Arunaloke Chakrabarti; Sharon C A Chen; Arnaldo Lopes Colombo; Martin Hoenigl; Nikolay Klimko; Cornelia Lass-Flörl; Rita O Oladele; Donald C Vinh; Li-Ping Zhu; Boris Böll; Roger Brüggemann; Jean-Pierre Gangneux; John R Perfect; Thomas F Patterson; Thorsten Persigehl; Jacques F Meis; Luis Ostrosky-Zeichner; P Lewis White; Paul E Verweij; Oliver A Cornely
Journal:  Lancet Infect Dis       Date:  2020-12-14       Impact factor: 25.071

8.  Mucormycosis with orbital compartment syndrome in a patient with COVID-19.

Authors:  Amanda Werthman-Ehrenreich
Journal:  Am J Emerg Med       Date:  2020-09-16       Impact factor: 4.093

9.  Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.

Authors:  Michele Bartoletti; Renato Pascale; Monica Cricca; Matteo Rinaldi; Angelo Maccaro; Linda Bussini; Giacomo Fornaro; Tommaso Tonetti; Giacinto Pizzilli; Eugenia Francalanci; Lorenzo Giuntoli; Arianna Rubin; Alessandra Moroni; Simone Ambretti; Filippo Trapani; Oana Vatamanu; Vito Marco Ranieri; Andrea Castelli; Massimo Baiocchi; Russell Lewis; Maddalena Giannella; Pierluigi Viale
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079
View more
  27 in total

Review 1.  Mucormycosis in COVID-19: A systematic review of literature.

Authors:  Shivaraj Nagalli; Nidhi Shankar Kikkeri
Journal:  Infez Med       Date:  2021-12-10

Review 2.  CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.

Authors:  Mandeep Garg; Nidhi Prabhakar; Valliappan Muthu; Shameema Farookh; Harsimran Kaur; Vikas Suri; Ritesh Agarwal
Journal:  Radiology       Date:  2021-08-31       Impact factor: 11.105

3.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

4.  Bronchial wall necrosis secondary to mucormycosis following SARS-Cov2 infection: A case report.

Authors:  Ghazal Arjmand; Elham Askari; Arya Kazemi; Ehsan Zarei; Sara Haseli; Nazanin Sadraei
Journal:  Radiol Case Rep       Date:  2022-06-17

Review 5.  High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.

Authors:  Kinal Bhatt; Arjola Agolli; Mehrie H Patel; Radhika Garimella; Madhuri Devi; Efrain Garcia; Harshad Amin; Carlos Domingue; Roberto Guerra Del Castillo; Marcos Sanchez-Gonzalez
Journal:  Discoveries (Craiova)       Date:  2021-03-31

Review 6.  COVID-19 associated mucormycosis - An emerging threat.

Authors:  Chien-Ming Chao; Chih-Cheng Lai; Wen-Liang Yu
Journal:  J Microbiol Immunol Infect       Date:  2022-01-13       Impact factor: 10.273

7.  In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi.

Authors:  Mohamed A Soltan; Muhammad Alaa Eldeen; Nada Elbassiouny; Hasnaa L Kamel; Kareem M Abdelraheem; Hanaa Abd El-Gayyed; Ahmed M Gouda; Mohammed F Sheha; Eman Fayad; Ola A Abu Ali; Khalid Abd El Ghany; Dalia A El-Damasy; Khaled M Darwish; Sameh S Elhady; Ashraf E Sileem
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

8.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

Review 9.  New insights on mucormycosis and its association with the COVID-19 pandemic.

Authors:  Mona G Alshahawey; Ghadir S El-Housseiny; Noha S Elsayed; Mohammad Y Alshahrani; Lamia Mel Wakeel; Khaled M Aboshanab
Journal:  Future Sci OA       Date:  2021-12-16

Review 10.  COVID-19 and mucormycosis superinfection: the perfect storm.

Authors:  Jaffar A Al-Tawfiq; Saad Alhumaid; Abeer N Alshukairi; Mohamad-Hani Temsah; Mazin Barry; Abbas Al Mutair; Ali A Rabaan; Awadh Al-Omari; Raghavendra Tirupathi; Manaf AlQahtani; Salma AlBahrani; Kuldeep Dhama
Journal:  Infection       Date:  2021-07-24       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.